By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


NanoViricides, Inc. 

135 Wood Street, Suite 205

West Haven  Connecticut  06516  U.S.A.
Phone: n/a Fax:


Company News
Ebola Clinical Trials: Big Name Players In The Ebola Race 10/20/2014 3:28:01 AM
NanoViricides, Inc. (NNVC.PK) CEO, Eugene Seymour, MD, MPH, Invited To Discuss The Current Ebola Outbreak On Fox Business News At 9PM EDT Tonight 10/7/2014 1:24:09 PM
NanoViricides, Inc. (NNVC.PK) Files Annual Report 10/1/2014 11:09:56 AM
NanoViricides, Inc. (NNVC.PK) Reports Flucideā„¢ Samples Were Shipped To Basi For Start Of Safety/Toxicology Studies; Also Reports That Ebola Drug Candidates Are Being Synthesized 10/1/2014 10:52:28 AM
NanoViricides, Inc. (NNVC.PK) Reports That It Has Designed And Commenced Synthesis Of Novel Ebola Drug Candidates; Dr. Seymour To Present At Rodman & Renshaw Conference In New York Today 9/9/2014 12:12:03 PM
NanoViricides, Inc. (NNVC.PK) Raises Approximately $7.5 Million Upon Exercise Of Certain Old Warrants By Its Long Standing Investors 9/8/2014 6:34:57 AM
NanoViricides, Inc. (NNVC.PK) To Ring Opening Bell At New York Stock Exchange 8/13/2014 7:48:06 AM
NanoViricides, Inc. (NNVC.PK) To Restart Its Anti-Ebola Virus Drug Development Program 8/4/2014 11:54:18 AM
NanoViricides, Inc. (NNVC.PK) President Dr. Diwan Was An Invited Participant At The Prestigious CEO Roundtable 7/23/2014 1:10:53 PM
NanoViricides, Inc. (NNVC.PK) Celebrated The Grand Opening Of Its New R&D And cGMP Pilot Manufacturing Facility With Congressman Jim Himes As The Chief Guest Yesterday 7/22/2014 11:53:23 AM